| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.25 | 4e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-08 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.28 | 8e-07 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.23 | 2e-06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |